Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Visual Compatibility Of Blinatumomab With Selected Drugs During Simulated Y-Site Administration

Theau Du Repaire,Petula Vigne,Amaury Guedon,Raphaelle Fanciullino,Laurence Gauthier-Villano,Pierre Bertault Peres,Bertrand Pourroy

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY（2017）

Cited 0|Views14
No score
Abstract
Blinatumomab is a bispecific T-cell engager antibody construct that binds specifically to CD19 expressed on the surface of cells of B-lineage origin and CD3 expressed on the surface of T cells.[1][1] Blinatumomab was approved by the European Medicines Agency for the treatment of adults with
More
Translated text
Key words
blinatumomab,drug incompatibility,drug stability,intravenous,oncology,pediatrics
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined